Overview

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Randomized phase II trial to study the effectiveness of various combination chemotherapy regimens in treating patients with acute lymphocytic leukemia.

Phase:

Phase 2

Details

Lead Sponsor:

Johann Wolfgang Goethe University Hospital

Treatments:

6-Mercaptopurine
Asparaginase
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Etoposide
Ifosfamide
Leucovorin
Levoleucovorin
Liposomal doxorubicin
Mercaptopurine
Methotrexate
Mitoxantrone
Prednisolone
Teniposide
Thioguanine
Vincristine
Vindesine